17 results
Efficacy and tolerability of FDA-approved atypical antipsychotics for the treatment of bipolar depression: a systematic review and network meta-analysis
-
- Journal:
- European Psychiatry / Volume 67 / Issue 1 / 2024
- Published online by Cambridge University Press:
- 15 March 2024, e29
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Clozapine haematological monitoring for neutropenia: a global perspective
-
- Journal:
- Epidemiology and Psychiatric Sciences / Volume 31 / 2022
- Published online by Cambridge University Press:
- 25 November 2022, e83
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
11 - Phase 1 Trials in Alzheimer’s Disease Drug Development
- from Section 3 - Alzheimer’s Disease Clinical Trials
-
-
- Book:
- Alzheimer's Disease Drug Development
- Published online:
- 03 March 2022
- Print publication:
- 31 March 2022, pp 135-149
-
- Chapter
- Export citation
Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study
-
- Journal:
- BJPsych Open / Volume 8 / Issue 1 / January 2022
- Published online by Cambridge University Press:
- 06 December 2021, e4
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Vortioxetine 20 mg/day in patients with major depressive disorder: updated analysis of efficacy, safety, and optimal timing of dose adjustment
-
- Journal:
- CNS Spectrums / Volume 28 / Issue 1 / February 2023
- Published online by Cambridge University Press:
- 18 October 2021, pp. 90-97
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Antipsychotic long-term treatment in children and young people: a systematic review and meta-analysis of efficacy and tolerability across mental health and neurodevelopmental conditions
-
- Journal:
- CNS Spectrums / Volume 27 / Issue 5 / October 2022
- Published online by Cambridge University Press:
- 24 May 2021, pp. 570-587
-
- Article
- Export citation
Second-generation antipsychotics: are their similarities greater than their differences?
-
- Journal:
- European Psychiatry / Volume 18 / Issue S2 / December 2003
- Published online by Cambridge University Press:
- 16 April 2020, pp. 38s-45s
-
- Article
- Export citation
Meta-analytic study of the benefits and risks of treating chronic schizophrenia with risperidone or conventional neuroleptics
-
- Journal:
- European Psychiatry / Volume 13 / Issue 6 / September 1998
- Published online by Cambridge University Press:
- 16 April 2020, pp. 310-314
-
- Article
- Export citation
A review of the safety of paroxetine
-
- Journal:
- European Psychiatry / Volume 8 / Issue S1 / 1993
- Published online by Cambridge University Press:
- 16 April 2020, pp. 25s-30s
-
- Article
- Export citation
Systematic review of the efficacy and tolerability of Clozapine in the treatment of youth with early onset schizophrenia
-
- Journal:
- European Psychiatry / Volume 29 / Issue 1 / January 2014
- Published online by Cambridge University Press:
- 15 April 2020, pp. 1-10
-
- Article
- Export citation
Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia
-
- Journal:
- CNS Spectrums / Volume 24 / Issue 4 / August 2019
- Published online by Cambridge University Press:
- 15 August 2018, pp. 395-403
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Switching stable patients with schizophrenia from their oral antipsychotics to aripiprazole lauroxil: a post hoc safety analysis of the initial 12-week crossover period
-
- Journal:
- CNS Spectrums / Volume 24 / Issue 4 / August 2019
- Published online by Cambridge University Press:
- 26 June 2018, pp. 419-425
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Pimavanserin for the treatment of Parkinson’s disease psychosis: number needed to treat, number needed to harm, and likelihood to be helped or harmed
-
- Journal:
- CNS Spectrums / Volume 23 / Issue 3 / June 2018
- Published online by Cambridge University Press:
- 03 November 2017, pp. 228-238
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study
-
- Journal:
- Psychological Medicine / Volume 46 / Issue 3 / February 2016
- Published online by Cambridge University Press:
- 19 October 2015, pp. 623-635
-
- Article
- Export citation
Efficacy and tolerability of blonanserin in 48 patients with intractable schizophrenia
-
- Journal:
- Acta Neuropsychiatrica / Volume 24 / Issue 6 / December 2012
- Published online by Cambridge University Press:
- 24 June 2014, pp. 380-383
-
- Article
- Export citation
Sustained drug delivery optimizes long-term treatment of patients with schizophrenia
-
- Journal:
- Acta Neuropsychiatrica / Volume 16 / Issue 6 / December 2004
- Published online by Cambridge University Press:
- 24 June 2014, pp. 319-325
-
- Article
- Export citation
Efficacy and safety of selegiline transdermal system (STS) for the atypical subtype of major depressive disorder: pooled analysis of 5 short-term, placebo-controlled trials
-
- Journal:
- CNS Spectrums / Volume 19 / Issue 4 / August 2014
- Published online by Cambridge University Press:
- 29 October 2013, pp. 324-329
-
- Article
- Export citation